Brief: Corcept Therapeutics Q2 EPS USD 0.36
29/07/2026 21:06
BRIEF-Corcept Therapeutics Q2 EPS USD 0.36 Jul 29 (Reuters) - Corcept Therapeutics Q2 revenue USD 256.147 million.
- Q2 net income USD 42.987 million
Recent news on Corcept Therapeutics Incorporated
See all newsDrugmaker Corcept seeks to bar ex-judge's views in Teva antitrust case
Live Markets: US earnings forecast jumps further after key reports this week
Live Markets: Who's next for the S&P 500? The clock is ticking
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Corcept Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary